Pancreatic cancer is one of the deadliest cancers — not because treatments don’t exist, but because most people are diagnosed too late. The PRECEDE Foundation is working to change that.
Early detection gives people a fighting chance, and here’s why.
The Problem
- Pancreatic cancer is usually found in late stages
- Symptoms are often subtle, so many people don’t know something is wrong
- Late diagnosis leads to fewer treatment options and lower survival rates
This is why early screening and risk awareness are so important.
Why Early Detection Matters
1. More Treatment Options
When cancer is caught early, patients are more likely to be eligible for surgery — which can significantly improve outcomes and survival.
2. Higher Survival Rates
Early-stage detection often means the cancer hasn’t spread, giving treatments a better chance of working.
3. Helps Identify At-Risk Individuals
Some people have a higher risk due to genetics or family history. Screening helps doctors monitor these individuals closely and catch cancer sooner.
4. Drives Better Science and Testing
Early detection research helps create better tools — such as new blood tests and improved imaging — that could become standard screenings in the future.
How PRECEDE Is Making an Impact
The PRECEDE Foundation is leading a global effort to improve early detection through:
- Over 60 medical centers worldwide working together
- Shared data and research, so progress happens faster
- Biopsy and biospecimen collection, helping scientists understand cancer earlier
- Innovative partnerships to develop new early screening methods
- A bold mission: raise pancreatic cancer’s 5-year survival rate from around 13% to 50%
This kind of collaboration is rare — and powerful.
How You Can Help
You can be part of the movement toward earlier detection:
- Learn your risk and share awareness with others
- Support screening and research efforts
- Donate to help expand early detection programs and studies
Every action helps move us closer to a future where pancreatic cancer is found earlier — and more lives are saved.
The Bottom Line
Early detection isn’t just beneficial — it’s lifesaving. By improving how and when we detect pancreatic cancer, we give patients the chance they deserve.
PRECEDE is working to make that future possible. Together, we can change the story.